{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:18:28Z","timestamp":1761862708798},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["ATVB"],"published-print":{"date-parts":[[2001,12]]},"abstract":"<jats:p>\n            Familial hypertriglyceridemia (FHTG), a disease characterized by elevated plasma very low density lipoprotein triglyceride levels, has been associated with impaired intestinal absorption of bile acids. The aim of this study was to test the hypothesis that defects in the active ileal absorption of bile acids are a primary cause of FHTG. Single-stranded conformation polymorphism analysis was used to screen the ileal Na\n            <jats:sup>+<\/jats:sup>\n            \/bile acid cotransporter gene (\n            <jats:italic>SLC10A2<\/jats:italic>\n            ) for FHTG-associated mutations. Analysis of 20 hypertriglyceridemic patients with abnormal bile acid metabolism revealed 3 missense mutations (V98I, V159I, and A171S), a frame-shift mutation (646insG) at codon 216, and 4 polymorphisms in the 5\u2032 flanking sequence of\n            <jats:italic>SLC10A2<\/jats:italic>\n            . The\n            <jats:italic>SLC10A2<\/jats:italic>\n            missense mutations and 5\u2032 flanking sequence polymorphisms were not correlated with bile acid production or turnover in the hypertriglyceridemic patients and were equally prevalent in the unaffected control subjects. In transfected COS cells, the V98I, V159I, and A171S isoforms all transported bile acids similar to the wild-type\n            <jats:italic>SLC10A2<\/jats:italic>\n            . The 646insG frame-shift mutation abolished bile acid transport activity in transfected COS cells but was found in only a single FHTG patient. These findings indicate that the decreased intestinal bile acid absorption in FHTG patients is not commonly associated with inherited defects in\n            <jats:italic>SLC10A2<\/jats:italic>\n            .\n          <\/jats:p>","DOI":"10.1161\/hq1201.100262","type":"journal-article","created":{"date-parts":[[2007,9,28]],"date-time":"2007-09-28T18:27:24Z","timestamp":1191004044000},"page":"2039-2045","update-policy":"http:\/\/dx.doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":37,"title":["Analysis of the Ileal Bile Acid Transporter Gene,\n            <i>SLC10A2<\/i>\n            , in Subjects With Familial Hypertriglyceridemia"],"prefix":"10.1161","volume":"21","author":[{"given":"Martha W.","family":"Love","sequence":"first","affiliation":[{"name":"From the Department of Internal Medicine (M.W.L., A.L.C., P.A.D.), Wake Forest University School of Medicine, Winston-Salem, NC; the Center for Metabolism and Endocrinology (B.A.), Department of Medicine, and Molecular Nutrition Unit (B.A.), Center for Nutrition and Toxicology, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden; the Division of Metabolism, Endocrinology, and Nutrition (J.D.B.), Department of Medicine, University of Washington, Seattle; and GI Section (W.C.D.),..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann L.","family":"Craddock","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine (M.W.L., A.L.C., P.A.D.), Wake Forest University School of Medicine, Winston-Salem, NC; the Center for Metabolism and Endocrinology (B.A.), Department of Medicine, and Molecular Nutrition Unit (B.A.), Center for Nutrition and Toxicology, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden; the Division of Metabolism, Endocrinology, and Nutrition (J.D.B.), Department of Medicine, University of Washington, Seattle; and GI Section (W.C.D.),..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Angelin","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine (M.W.L., A.L.C., P.A.D.), Wake Forest University School of Medicine, Winston-Salem, NC; the Center for Metabolism and Endocrinology (B.A.), Department of Medicine, and Molecular Nutrition Unit (B.A.), Center for Nutrition and Toxicology, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden; the Division of Metabolism, Endocrinology, and Nutrition (J.D.B.), Department of Medicine, University of Washington, Seattle; and GI Section (W.C.D.),..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Brunzell","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine (M.W.L., A.L.C., P.A.D.), Wake Forest University School of Medicine, Winston-Salem, NC; the Center for Metabolism and Endocrinology (B.A.), Department of Medicine, and Molecular Nutrition Unit (B.A.), Center for Nutrition and Toxicology, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden; the Division of Metabolism, Endocrinology, and Nutrition (J.D.B.), Department of Medicine, University of Washington, Seattle; and GI Section (W.C.D.),..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Duane","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine (M.W.L., A.L.C., P.A.D.), Wake Forest University School of Medicine, Winston-Salem, NC; the Center for Metabolism and Endocrinology (B.A.), Department of Medicine, and Molecular Nutrition Unit (B.A.), Center for Nutrition and Toxicology, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden; the Division of Metabolism, Endocrinology, and Nutrition (J.D.B.), Department of Medicine, University of Washington, Seattle; and GI Section (W.C.D.),..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Dawson","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine (M.W.L., A.L.C., P.A.D.), Wake Forest University School of Medicine, Winston-Salem, NC; the Center for Metabolism and Endocrinology (B.A.), Department of Medicine, and Molecular Nutrition Unit (B.A.), Center for Nutrition and Toxicology, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden; the Division of Metabolism, Endocrinology, and Nutrition (J.D.B.), Department of Medicine, University of Washington, Seattle; and GI Section (W.C.D.),..."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107332"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)38008-1"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1980.tb00004.x"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1980.tb02076.x"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(81)90064-0"},{"key":"e_1_3_3_6_2","first-page":"94","volume":"78","year":"1971","unstructured":"Grundy SM, Ahrens EH, Salen G. Interruption of the enterohepatic circulation of bile acids in man; comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. J Lab Clin Med. 1971; 78: 94\u2013121.","journal-title":"J Lab Clin Med"},{"key":"e_1_3_3_7_2","first-page":"1008","volume":"88","year":"1976","unstructured":"Witztum JL, Schonfeld G, Weidman SW. The effects of colestipol on the metabolism of very-low-density lipoproteins in man. J Lab Clin Med. 1976; 88: 1008\u20131018.","journal-title":"J Lab Clin Med"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)40685-6"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(82)90231-1"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.8.1116"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-95-3-257"},{"key":"e_1_3_3_12_2","first-page":"929","volume":"2","year":"1974","unstructured":"Miller NE, Nestel PJ. Triglyceride-lowering effect of chenodeoxycholic acid in patients with endogenous hypertriglyceridemia. Lancet. 1974; 2: 929\u2013931.","journal-title":"Lancet"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1978.tb00843.x"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(74)90120-6"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)40684-4"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.15.5434"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)39758-3"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)37287-4"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041433-199806000-00007"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119355"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)33450-7"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)37629-X"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1995.tb01552.x"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1957.tb01473.x"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.5.698"},{"key":"e_1_3_3_26_2","first-page":"G157","volume":"274","year":"1998","unstructured":"Craddock AL, Love MW, Daniel RW, Kirby LC, Walters HC, Wong MH, Dawson PA. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol. 1998; 274: G157\u2013G169.","journal-title":"Am J Physiol"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/86871"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)00050-2"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)00051-4"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R100035200"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm0002127"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)00062-3"}],"container-title":["Arteriosclerosis, Thrombosis, and Vascular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/hq1201.100262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T02:29:17Z","timestamp":1715653757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/hq1201.100262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["10.1161\/hq1201.100262"],"URL":"https:\/\/doi.org\/10.1161\/hq1201.100262","relation":{},"ISSN":["1079-5642","1524-4636"],"issn-type":[{"value":"1079-5642","type":"print"},{"value":"1524-4636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12]]},"assertion":[{"value":"2001-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}